Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Aswhin N. Ananthakrishnan"'
Autor:
Ioannis E. Koutroubakis, Simon Travis, Edward V. Loftus, Bruce E. Sands, Yehuda Chowers, Arthur Kaser, Antonino Spinelli, Maria T. Abreu, Gerassimos J. Mantzaris, Gerhard Rogler, Parambir S. Dulai, Milan Lukas, Dan Turner, Ailsa Hart, Colm O'Morain, Jonas Halfvarson, Matthieu Allez, Severine Vermeire, Silvio Danese, Geert R. D'Haens, William J. Sandborn, Walter Reinisch, Siew C. Ng, Subrata Ghosh, Flavio Steinwurz, Pia Munkholm, Jean-Frederic Colombel, Remo Panaccione, Stefan Schreiber, David B. Sachar, Laurent Peyrin-Biroulet, Julián Panés, Vipul Jairath, Aswhin N. Ananthakrishnan, Peter R. Gibson, Wolfgang Kruis, Catherine Le Berre, Iris Dotan, David T. Rubin
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, 160(5), 1452-1460.e21. W.B. Saunders Ltd
Gastroenterology, Elsevier, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, WB Saunders, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, 160(5), 1452-1460.e21. W.B. Saunders Ltd
Gastroenterology, Elsevier, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
International audience; Background and aims: Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease-modification trials to prevent disease progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdfd72625f12282fdbd4a9584309a3f3
https://doi.org/10.1053/j.gastro.2020.10.065
https://doi.org/10.1053/j.gastro.2020.10.065
